Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group database

Arthritis and Rheumatism

Volumn 62, Issue 2, 2010, Pages 616-626

  Pagnoux, Christian ^a   Seror, Raphaèle ^a   Henegar, Corneliu ^b   Mahr, Alfred ^a   Cohen, Pascal ^a   Le Guern, Véronique ^a   Bienvenu, Boris ^c   Mouthon, Luc ^a   Guillevin, Loïc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; DATA BASE; DEATH; DISEASE REGISTRY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SURGERY; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROANEURYSM; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; ORCHITIS; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; POLYARTERITIS NODOSA; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELAPSE; RENAL ARTERY; RETROSPECTIVE STUDY; SKIN; SKIN MANIFESTATION; SURGEON;

ABDOMINAL PAIN; ADULT; AGED; ANEURYSM; BIOPSY; COMORBIDITY; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; HYPERTENSION; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYARTERITIS NODOSA; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 75749097716     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27240     Document Type: Article

References (40)

1. Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1866;1:484-518.
2. Frohnert P, Sheps S. Long term follow-up study of periarteritis nodosa. Am J Med 1967;43:8-14.
3. Leib ES, Restivo C, Paulus HE. Immunosuppressive and cortico-steroid therapy of polyarteritis nodosa. Am J Med 1979;67:941-7.
4. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 1980;55:146-55.
5. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988;27:258-64.
6. Wohlwill F. Ueber die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch Pathol Anat 1923;246:377-411.
7. Davson J, Ball J, Platt R. Kidney in periarteritis nodosa. Q J Med 1948;17:175-202.
8. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
9. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-23.
10. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
11. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9.
12. Guillevin L, Cohen P, Mahr A, Arene JP, Mouthon L, Puechal X, et al, and the French Vasculitis Study Group. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003;49:93-100.
13. Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84:313-22.
14. Guillevin L, Merrouche Y, Gayraud M, Jarrousse B, Royer I, Leon A, et al. Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases. Presse Med 1988;17:1522-6. In French.
15. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995;74:238-53.
16. Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients. Arthritis Rheum 1992;35:208-15.
17. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
18. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
19. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.
20. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;87:161-7.
21. Peto R, Pike MC. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 1973;29:579-84.
22. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-219.
23. SAS Institute: SAS technical report. Cary (NC): SAS Institute; 1992. p. 229.
24. Guillevin L, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, et al, the French Vasculitis Study Group (FVSG). Treatment of HBV-related polyarteritis nodosa (PAN) with lamivudine and plasma exchanges: a prospective, multicenter, pilot trial in 10 patients [abstract]. Arthritis Rheum 2001;44 Suppl:S271.
25. Guillevin L, Jarrousse B, Lok C, Lhote F, Jais JP, Le Thi Huong Du D, et al, the Cooperative Study Group for Polyarteritis Nodosa. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange: a prospective randomized trial of 71 patients. J Rheumatol 1991;18:567-74.
26. Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995;38:1638-45.
27. Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients. J Rheumatol 1993;20:289-98.
28. Cohen P, Pagnoux C, Mahr A, Mouthon L, Puechal X, Le Guern V, et al, French Vasculitis Study Group (FVSG). Treatment of non-HBV polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with corticosteroids (CS) alone: preliminary results of a prospective, multicenter trial in France [abstract]. Arthritis Rheum 2003;48 Suppl:S209.
29. Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, et al, French Cooperative Study Group for Vasculitides. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol 1997;36:1290-7.
30. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al, for the EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.
31. Fauci AS, Haynes B, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-76.
32. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-7.
33. Henegar C, Pagnoux C, Puechal X, Zucker JD, Bar-Hen A, Le Guern V, et al, for the French Vasculitis Study Group. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008;58:1528-38.
34. Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 2005;7:270-5.
35. Mouthon L, Le Toumelin P, Andre MH, Gayraud M, Casassus P, Guillevin L. Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years. Medicine (Baltimore) 2002;81:27-40.
36. Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005;84:323-30.
37. Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005;84:115-28.
38. Fortin PR, Larson MG, Watters AK, Yeadon CA, Choquette D, Esdaile JM. Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group - a review of 45 cases. J Rheumatol 1995;22:78-84.
39. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 1997;136:706-13.
40. Diaz-Perez JL, De Lagran ZM, Diaz-Ramon JL, Winkelmann RK. Cutaneous polyarteritis nodosa. Semin Cutan Med Surg 2007;26:77-86.